Zynex, Inc. (ZYXI)
| Market Cap | 495.71M |
| Revenue (ttm) | 80.12M |
| Net Income (ttm) | 9.07M |
| Shares Out | 33.87M |
| EPS (ttm) | 0.26 |
| PE Ratio | 54.81 |
| Forward PE | 46.95 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 2 |
| Last Price | $14.25 |
| Previous Close | $14.69 |
| Change ($) | -0.44 |
| Change (%) | -3.00% |
| Day's Open | 14.74 |
| Day's Range | 14.21 - 14.93 |
| Day's Volume | 884,424 |
| 52-Week Range | 7.93 - 29.73 |
With the trading day more than halfway over, the broad markets recovered slightly from Thursday's downturn, with the exception of the Dow Jones industrial average.
Investors are reacting negatively to the company's Q4 results and Q1 outlook.
Shares of Zynex (NASDAQ:ZYXI) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 44.44% over the past year to $0.05, which misse...
ENGLEWOOD, Colo., Feb. 25, 2021 /PRNewswire/ -- 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net income of $9.1 million; Diluted EPS $0.26 Adjusted...
ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...
ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...
ENGLEWOOD, Colo., Jan. 14, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...
ENGLEWOOD, Colo., Jan. 6, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...
These three small-cap stocks all turned a profit last quarter and present ample growth potential at bargain prices.
ENGLEWOOD, Colo., Nov. 19, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...
ENGLEWOOD, Colo., Nov. 17, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...
Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q3 2020 Results - Earnings Call Transcript
Shares of Zynex (NASDAQ:ZYXI) decreased 2.79% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 33.33% year over year to $0.04, which mis...
ENGLEWOOD, Colo., Oct. 27, 2020 /PRNewswire/ -- Revenue increased 69% year over year to $20.0 million Orders increased 96% Net income of $1.3 million; Diluted EPS $0.04 Adjusted EBITDA $2.4 mi...
Shares have been taken down yet again, on a mild guidance decrease. However, order growth has come back strongly and revenues will follow that.
Zynex Appoints Neil Friery as President and Chief Operating Officer of Monitoring Solutions Division
ENGLEWOOD, Colo., Oct. 23, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...
ENGLEWOOD, Colo., Oct. 20, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...
The medical technology company's revenue isn't growing as much as hoped.
ENGLEWOOD, Co., Oct. 12, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pa...
Zynex: 'Electric' Growth And Strong Earnings Keep Us Bullish
A Relative Strength Rating upgrade for Zynex shows improving technical performance. Will it continue?
A Relative Strength Rating upgrade for Zynex shows improving technical performance. The post Zynex Shows Market Leadership With Jump To 82 RS Rating appeared first on Investor's Business Daily.
These stocks are much cheaper than they were a few months ago and have great long-term prospects.
Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q2 2020 Results - Earnings Call Transcript
Shares of Zynex (NASDAQ:ZYXI) increased 2.65% in after-market trading after the company reported Q2 results.
ENGLEWOOD, Colo., July 28, 2020 /PRNewswire/ -- Zynex, Inc.
Zynex's (ZYXI) April orders down approximately 35% from the January and February average. This may have impacted its Q2 earnings.
There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.
The company announced the pricing of a public offering of common stock.
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical de...
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical de...
ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for p...
This selection of growth stocks includes some surprise choices and companies set to benefit from the lasting effects of the pandemic.
Zynex climbed to record highs on Thursday, but there are reasons to pump the brakes on this medical equipment company.
NEW YORK, June 10, 2020 /PRNewswire/ -- Zynex Inc. (NASD:ZYXI) will replace KEMET Corp. (NYSE:KEM) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, June 16. Yageo ...
How I Find The Right Start-Up To Invest In
ENGLEWOOD, Colo., May 18, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...
Top Stock Picks for Week of May 11, 2020
Two Medical Products Stocks with Recent Price Strength.
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Top Ranked Momentum Stocks to Buy for May 5th
An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.
Here’s a list of all the top-rated growth stocks that have just been added to the IBD 50, IBD Big Cap 20, Sector Leaders, Stock Spotlight and IPO leaders. The post Medical Device Maker Zynex J...
Zynex's (ZYXI) CEO Thomas Sandgaard on Q1 2020 Results - Earnings Call Transcript
As of late, it has definitely been a great time to be an investor Zynex
Zynex Inc. (NASDAQ: ZYXI) shares are trading higher on Tuesday, after the company raised its first-quarter and fiscal year 2020 guidance.
Zynex has been struggling lately, but the selling pressure may be coming to an end soon.
Top Ranked Momentum Stocks to Buy for February 28th
Zynex's (ZYXI) CEO Thomas Sandgaard on Q4 2019 Results - Earnings Call Transcript
About ZYXI
Zynex, through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and... [Read more...]
| Industry Medical Devices | Founded 1996 |
| CEO Thomas Sandgaard | Employees 768 |
| Stock Exchange NASDAQ | Ticker Symbol ZYXI |
Financial Performance
In 2020, Zynex's revenue was $80.12 million, an increase of 76.20% compared to the previous year's $45.47 million. Earnings were $9.07 million, a decrease of -4.40%.
Analyst Forecasts
According to 5 analysts, the average rating for Zynex stock is "Strong Buy." The 12-month stock price forecast is 24.70, which is an increase of 73.33% from the latest price.